Temsirolimus 7-O-Desmethyl Impurity is a structurally related impurity derived from the parent mTOR inhibitor temsirolimus, characterized by the absence of a methyl group at the 7-O position of the sirolane core. This modification disrupts the glycosylated linkage, exposing a deoxygenated hydroxyl functionality adjacent to the macrolide lactone ring. The molecule retains the triene conjugation system and phosphorylated amino sugar moieties critical for pharmacophore interactions. Synthetically, it arises during demethylation steps in late-stage temsirolimus production, serving as a key HPLC reference standard for impurity profiling in quality control.
On RequestC[C@@H]1CC[C@H]2C[C@@H](C(=CC=CC=C[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)C)O
InChI=1S/C55H85NO16/c1-32-16-12-11-13-17-33(2)42(59)28-40-21-19-38(7)55(67,72-40)50(63)51(64)56-23-15-14-18-41(56)52(65)70-45(29-43(60)34(3)25-37(6)48(62)49(69-10)47(61)36(5)24-32)35(4)26-39-20-22-44(46(27-39)68-9)71-53(66)54(8,30-57)31-58/h11-13,16-17,25,32,34-36,38-42,44-46,48-49,57-59,62,67H,14-15,18-24,26-31H2,1-10H3/b13-11?,16-12?,33-17?,37-25+/t32-,34-,35-,36-,38-,39+,40+,41+,42+,44-,45+,46-,48-,49+,55-/m1/s1
CJDQIEOIQZFHOU-UHKBLVRYSA-N